Corebridge Reports Net Loss, Announces Major Share Repurchases Amidst CFO Resignation and Strategic Reinsurance
Summary
Corebridge Financial reported a net loss of $366 million for 2025, a significant reversal from the prior year, but also executed $2.1 billion in share repurchases and completed a major reinsurance transaction to de-risk its variable annuity business. The company also announced a new CEO and a CFO resignation.
Key Events
-
Reports Significant Net Loss for 2025
Corebridge Financial recorded a net loss of $366 million for the year ended December 31, 2025, a substantial decrease from a net income of $2.23 billion in 2024. This was primarily due to higher net realized losses of $2.1 billion and increased policyholder benefits of $1.5 billion.
-
Authorizes and Executes Major Share Repurchases
The company repurchased approximately 35.7 million shares for $1.1 billion in Q4 2025, contributing to a total of $2.1 billion in repurchases for the full year. The Board also authorized an additional $2.0 billion increase to the share repurchase program, signaling continued commitment to capital return.
-
Completes Large-Scale Variable Annuity Reinsurance
Corebridge finalized the cession of $5.0 billion in General Account liabilities and $45.2 billion in Separate Accounts liabilities from its individual variable annuity business to Corporate Solutions Life Reinsurance Company (CSLR). This strategic move, which closed in August 2025 and January 2026, significantly de-risks the company's liability profile.
-
Key Executive Changes Announced
Marc Costantini was appointed President and CEO in December 2025. Concurrently, Elias Habayeb notified the company of his intent to resign as Chief Financial Officer, with a transition period ending April 24, 2026.
Analysis
Corebridge Financial's annual 10-K filing reveals a significant shift to a net loss of $366 million for 2025, a substantial decline from the prior year's net income. This underperformance was primarily driven by higher net realized losses and increased policyholder benefits. However, the company demonstrated a strong commitment to shareholder returns by repurchasing $2.1 billion in common stock during 2025 and authorizing an additional $2.0 billion for future repurchases. The completion of a large-scale reinsurance transaction, ceding $50.2 billion in variable annuity liabilities, represents a strategic de-risking move. The filing also notes the appointment of a new CEO in December 2025, providing leadership stability, but also the resignation of the CFO, which introduces some uncertainty. Investors should weigh the financial underperformance against the company's proactive capital management and risk reduction strategies.
At the time of this filing, CRBG was trading at $31.12 on NYSE in the Finance sector, with a market capitalization of approximately $16.2B. The 52-week trading range was $23.69 to $36.57. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.